Jason Christie
Overview
Explore the profile of Jason Christie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
735
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cantu E, Diamond J, Ganjoo N, Nottigham A, Ramon C, McCurry M, et al.
Am J Transplant
. 2024 Jan;
24(5):839-849.
PMID: 38266712
Lung transplantation lags behind other solid organ transplants in donor lung utilization due, in part, to uncertainty regarding donor quality. We sought to develop an easy-to-use donor risk metric that,...
2.
Anderson M, Kim J, Podolanczuk A, Ding J, Al-Naamani N, Allison M, et al.
Obes Sci Pract
. 2024 Jan;
10(1):e708.
PMID: 38263991
Objective: Long pentraxin-3 (PTX-3) is an acute phase protein associated with cardiovascular disease, lung injury, and mortality. We evaluated the association between computed tomography (CT)-measurements of adipose tissue and plasma...
3.
Hunt M, Crespo M, Richards T, Bermudez F, Courtwright A, Usman A, et al.
J Thorac Cardiovasc Surg
. 2024 Jan;
168(3):712-721.e2.
PMID: 38199292
Objective: Lung transplant for acute respiratory distress syndrome in patients supported with extracorporeal membrane oxygenation was rare before 2020, but was rapidly adopted to rescue patients with COVID-19 with lung...
4.
Aguilar O, Qualls A, Gonzalez-Hinojosa M, Obeidalla S, Kerchberger V, Tsao T, et al.
Am J Respir Crit Care Med
. 2023 Oct;
209(1):70-82.
PMID: 37878820
Acute lung injury (ALI) carries a high risk of mortality but has no established pharmacologic therapy. We previously found that experimental ALI occurs through natural killer (NK) cell NKG2D receptor...
5.
Bermudez C, Bermudez F, Courtwright A, Richards T, Diamond J, Cevasco M, et al.
J Thorac Cardiovasc Surg
. 2023 Apr;
167(1):384-395.e3.
PMID: 37087098
Objective: Patients with end-stage respiratory failure after severe coronavirus disease 2019 (COVID-19) infection may benefit from lung transplant; however, data on transplant outcomes and the impact of prolonged circulatory support...
6.
McQuiston A, Emtiazjoo A, Angel P, Machuca T, Christie J, Atkinson C
Front Immunol
. 2021 Aug;
12:711102.
PMID: 34456920
Lung transplant patients have the lowest long-term survival rates compared to other solid organ transplants. The complications after lung transplantation such as primary graft dysfunction (PGD) and ultimately chronic lung...
7.
Li C, Patel K, Tu Z, Yang X, Kulik L, Alawieh A, et al.
Am J Transplant
. 2020 Nov;
21(6):2067-2078.
PMID: 33210808
Complement is known to play a role in ischemia and reperfusion injury (IRI). A general paradigm is that complement is activated by self-reactive natural IgM antibodies (nAbs), after they engage...
8.
Self W, Semler M, Leither L, Casey J, Angus D, Brower R, et al.
JAMA
. 2020 Nov;
324(21):2165-2176.
PMID: 33165621
Importance: Data on the efficacy of hydroxychloroquine for the treatment of coronavirus disease 2019 (COVID-19) are needed. Objective: To determine whether hydroxychloroquine is an efficacious treatment for adults hospitalized with...
9.
Javaheri A, Molina M, Zamani P, Rodrigues A, Novak E, Chambers S, et al.
J Heart Lung Transplant
. 2016 Aug;
35(11):1295-1302.
PMID: 27498384
Background: Cardiac allograft vasculopathy (CAV) is a major cause of mortality after cardiac transplantation. High-density lipoprotein (HDL) cholesterol efflux capacity (CEC) is inversely associated with coronary artery disease. In 2...
10.
Christie J, Lazaar A, Bayliffe A
Crit Care Med
. 2016 May;
44(6):e454-5.
PMID: 27182882
No abstract available.